| Heather Rae Schumann, MD | |
|
13250 Hazel Dell Pkwy Ste 104, Carmel, IN 46033 | |
| (317) 415-6900 | |
| Not Available |
| Full Name | Heather Rae Schumann |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 13250 Hazel Dell Pkwy Ste 104, Carmel, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073596839 | NPI | - | NPPES |
| 200157700 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01047182A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Medical Group Inc | 7012047640 | 625 |
News Archive
A team of researchers from the UCH CEU's Biomedical Sciences Institute has tested the efficiency of Bevacizumab, medicine used against cancer and in ophtalmology, to treat uveítis, thus stopping the inflammation from spreading.
Scientists in Tokyo have discovered a new protein, named PICT-1, that is involved in regulating PTEN, the second most commonly mutated tumor suppressor in human tumors.
Johns Hopkins researchers have identified a natural mechanism that might one day be used to block the expression of the mutated gene known to cause Huntington's disease.
Doctors in Canada have discovered that treating high-risk prostate cancer patients with radiation therapy and adding hormone therapy for more than one year allows patients to live longer, have better control of their prostate specific antigen levels and lowers the rate of death specifically from prostate cancer
"Specialty drugs" have become important treatment options for many serious and chronic diseases, and in some conditions like cancer they represent the only chance for long-term survival.
› Verified 3 days ago
| Entity Name | St Vincent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144513375 PECOS PAC ID: 7012047640 Enrollment ID: O20100609000045 |
News Archive
A team of researchers from the UCH CEU's Biomedical Sciences Institute has tested the efficiency of Bevacizumab, medicine used against cancer and in ophtalmology, to treat uveítis, thus stopping the inflammation from spreading.
Scientists in Tokyo have discovered a new protein, named PICT-1, that is involved in regulating PTEN, the second most commonly mutated tumor suppressor in human tumors.
Johns Hopkins researchers have identified a natural mechanism that might one day be used to block the expression of the mutated gene known to cause Huntington's disease.
Doctors in Canada have discovered that treating high-risk prostate cancer patients with radiation therapy and adding hormone therapy for more than one year allows patients to live longer, have better control of their prostate specific antigen levels and lowers the rate of death specifically from prostate cancer
"Specialty drugs" have become important treatment options for many serious and chronic diseases, and in some conditions like cancer they represent the only chance for long-term survival.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heather Rae Schumann, MD 10330 N Meridian St # 300, Indianapolis, IN 46290-1024 Ph: () - | Heather Rae Schumann, MD 13250 Hazel Dell Pkwy Ste 104, Carmel, IN 46033 Ph: (317) 415-6900 |
News Archive
A team of researchers from the UCH CEU's Biomedical Sciences Institute has tested the efficiency of Bevacizumab, medicine used against cancer and in ophtalmology, to treat uveítis, thus stopping the inflammation from spreading.
Scientists in Tokyo have discovered a new protein, named PICT-1, that is involved in regulating PTEN, the second most commonly mutated tumor suppressor in human tumors.
Johns Hopkins researchers have identified a natural mechanism that might one day be used to block the expression of the mutated gene known to cause Huntington's disease.
Doctors in Canada have discovered that treating high-risk prostate cancer patients with radiation therapy and adding hormone therapy for more than one year allows patients to live longer, have better control of their prostate specific antigen levels and lowers the rate of death specifically from prostate cancer
"Specialty drugs" have become important treatment options for many serious and chronic diseases, and in some conditions like cancer they represent the only chance for long-term survival.
› Verified 3 days ago
Amanda Houchens, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12188b N Meridian St Ste 280, Carmel, IN 46032 Phone: 317-705-4550 Fax: 317-705-4559 | |
Sanju J Daftari, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11911 N Meridian St, Suite 150, Carmel, IN 46032 Phone: 317-621-6701 Fax: 317-621-6707 | |
Rachel Land, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 12188b N Meridian St Ste 280, Carmel, IN 46032 Phone: 317-705-4550 Fax: 317-705-4559 | |
Robert D Habig, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 15229 Westfield Blvd, Carmel, IN 46032 Phone: 317-867-1236 Fax: 317-896-1299 | |
Erica Dryden Leazenby, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 13250 Hazel Dell Pkwy, Suite 104, Carmel, IN 46033 Phone: 317-415-6900 Fax: 317-415-6910 | |
Catherine E Broach, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 13250 Hazel Dell Pkwy Ste 104, Carmel, IN 46033 Phone: 317-415-6900 |